Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease

BACKGROUND: The treatment effects on hospitalization for heart failure (hHF) from sodium-glucose cotransporter 2 (SGLT2) inhibitors may vary among type 2 diabetes (T2D) patients depending on whether or not they have established atherosclerotic cardiovascular diseases (ASCVD). We aimed to examine dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shih-Chieh, Chang, Kai-Cheng, Lin, Swu-Jane, Chang, Shang-Hung, Hung, Ming-Jui, Chan, Yuk-Ying, Lai, Edward Chia-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542324/
https://www.ncbi.nlm.nih.gov/pubmed/34688282
http://dx.doi.org/10.1186/s12933-021-01406-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542324/
https://www.ncbi.nlm.nih.gov/pubmed/34688282
http://dx.doi.org/10.1186/s12933-021-01406-3

Ejemplares similares